Efficacy, safety profile, and immunogenicity of alglucosidase alfa produced at the 4,000-liter scale in US children and adolescents with Pompe disease: ADVANCE, a phase IV, open-label, prospective study

Si Houn Hahn, Priya S. Kishnani, Nancy D. Leslie et al.|Genetics in Medicine|2018

Cited by 31